Papers/PMID:39774829
Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.
PloS one2025The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
metformin — decreases oesophageal cancer incidence
Evidence strength: moderate.Finding“The random effects model showed that compared with the control groups, metformin might decrease EC incidence (OR = 0.87, P = 0.04).”
Quoted verbatim from Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Patients with diabetes; 12 observational studies (cohort and case-control) of metformin use versus non-use, pooled incidence of esophageal cancer
Effect 0.87 odds ratio
Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.2025PMID:3977482910.1371/journal.pone.0310687Permalink